Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 685

1.

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

Hicklin DJ, Ellis LM.

J Clin Oncol. 2005 Feb 10;23(5):1011-27. Epub 2004 Dec 7. Review.

PMID:
15585754
[PubMed - indexed for MEDLINE]
Free Article
2.

Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy.

Veeravagu A, Hsu AR, Cai W, Hou LC, Tse VC, Chen X.

Recent Pat Anticancer Drug Discov. 2007 Jan;2(1):59-71. Review.

PMID:
18221053
[PubMed - indexed for MEDLINE]
3.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
[PubMed - indexed for MEDLINE]
4.

Vascular endothelial growth factor and its inhibitors.

Verheul HM, Pinedo HM.

Drugs Today (Barc). 2003;39 Suppl C:81-93. Review.

PMID:
14988747
[PubMed - indexed for MEDLINE]
5.

Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis.

Shibuya M.

BMB Rep. 2008 Apr 30;41(4):278-86. Review.

PMID:
18452647
[PubMed - indexed for MEDLINE]
Free Article
6.

Vascular endothelial growth factor (VEGF) inhibition--a critical review.

Moreira IS, Fernandes PA, Ramos MJ.

Anticancer Agents Med Chem. 2007 Mar;7(2):223-45. Review.

PMID:
17348829
[PubMed - indexed for MEDLINE]
7.

VEGF receptor signaling in tumor angiogenesis.

McMahon G.

Oncologist. 2000;5 Suppl 1:3-10. Review.

PMID:
10804084
[PubMed - indexed for MEDLINE]
Free Article
8.

Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF).

Byrne AM, Bouchier-Hayes DJ, Harmey JH.

J Cell Mol Med. 2005 Oct-Dec;9(4):777-94. Review.

PMID:
16364190
[PubMed - indexed for MEDLINE]
9.

Vascular endothelial growth factor as a target for anticancer therapy.

Ferrara N.

Oncologist. 2004;9 Suppl 1:2-10. Review.

PMID:
15178810
[PubMed - indexed for MEDLINE]
Free Article
10.

[VEGF, anti-vEGF and diseases].

Corvol P.

Bull Acad Natl Med. 2008 Feb;192(2):289-300; discussion 300-2. Review. French.

PMID:
18819684
[PubMed - indexed for MEDLINE]
11.

The role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGF-receptor kinase inhibitors.

Verheul HM, Pinedo HM.

Clin Breast Cancer. 2000 Sep;1 Suppl 1:S80-4. Review.

PMID:
11970755
[PubMed - indexed for MEDLINE]
12.

Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.

Shibuya M.

FEBS J. 2009 Sep;276(17):4636-43. doi: 10.1111/j.1742-4658.2009.07175.x. Epub 2009 Jul 31. Review.

PMID:
19664071
[PubMed - indexed for MEDLINE]
13.

Antiangiogenic therapy in malignant glioma: promise and challenge.

Sathornsumetee S, Rich JN.

Curr Pharm Des. 2007;13(35):3545-58. Review.

PMID:
18220791
[PubMed - indexed for MEDLINE]
14.

Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.

Pradeep CR, Sunila ES, Kuttan G.

Integr Cancer Ther. 2005 Dec;4(4):315-21. Review.

PMID:
16282508
[PubMed - indexed for MEDLINE]
15.

Vascular endothelial growth factor as a therapeutic target in cancer.

Bergsland EK.

Am J Health Syst Pharm. 2004 Nov 1;61(21 Suppl 5):S4-11. Review.

PMID:
15552621
[PubMed - indexed for MEDLINE]
16.

Vascular endothelial growth factor receptors: expression and function in solid tumors.

Wey JS, Stoeltzing O, Ellis LM.

Clin Adv Hematol Oncol. 2004 Jan;2(1):37-45. Review.

PMID:
16163158
[PubMed - indexed for MEDLINE]
17.

III. Angiogenesis: complexity of tumor vasculature and microenvironment.

Furuya M, Yonemitsu Y, Aoki I.

Curr Pharm Des. 2009;15(16):1854-67. Review.

PMID:
19519428
[PubMed - indexed for MEDLINE]
18.

The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.

Takahashi H, Shibuya M.

Clin Sci (Lond). 2005 Sep;109(3):227-41. Review.

PMID:
16104843
[PubMed - indexed for MEDLINE]
Free Article
19.

Targeting tumor angiogenesis.

Gaur P, Bose D, Samuel S, Ellis LM.

Semin Oncol. 2009 Apr;36(2 Suppl 1):S12-9. doi: 10.1053/j.seminoncol.2009.02.002.

PMID:
19393831
[PubMed - indexed for MEDLINE]
20.

The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.

Langer CJ, Natale RB.

Semin Oncol. 2005 Dec;32(6 Suppl 10):S23-9. Review.

PMID:
16459176
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk